-- Significant Progress Over First Four Months of Joint Research -- Cambridge, MA - January 7, 2011 - Anchor Therapeutics today announced that it has successfully completed the first stage of its …
News
EUSA Pharma Announces Priority Review Status for ERWINAZE® BLA
Langhorne, PA and Oxford, UK – 5 January 2011 EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its …